LindseyMarieHoffmanDO

Pediatric Hematology & Oncology • Phoenix, AZ

Pediatric Neuro-Oncology

Join to view full profile

Dr. Hoffman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoffman's full profile

Already have an account?

Office
1919 E Thomas Rd
Phoenix, AZ 85016
Phone+1 602-933-0920

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Baylor College of Medicine (Houston)Residency, Pediatrics, 2008 - 2011
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2008

Certifications & Licensure

AZ State License 2019 - 2026
CO State License 2010 - 2021
OH State License 2014 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors Start of enrollment: 2015 Jun 01
Recruiting
Phase 2
Tocilizumab in Children With ACP Start of enrollment: 2019 Sep 06
Recruiting
Early Phase 1
Pediatric Long-Term Follow-up and Rollover Study Start of enrollment: 2019 Nov 04
Recruiting
Phase 4
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.
Ariana M Familiar, Anahita Fathi Kazerooni, Arastoo Vossough, Jeffrey B Ware, Sina Bagheri
Neuro-Oncology. 2024-09-05
222 citations
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the Inte...
Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz, Joshua J Baugh, Brooklyn Chaney
Journal of Clinical Oncology. 2018-05-10
84 citations
Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.
Tabitha Cooney, Adam Lane, Ute Bartels, Eric Bouffet, Stewart Goldman
Neuro-Oncology. 2016-06-01

Journal Articles

Correction to: A Suggestion to Introduce the Diagnosis of “Diffuse Midline Glioma of the Pons, H3 K27 Wildtype (WHO Grade IV)”
Lindsey M Hoffman, Maryam Fouladi, Acta Neuropathologica

Press Mentions

SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain CancerSeptember 13th, 2022